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Abstract. HIV testing is a ‘gateway’ technology, enabling access to treatment and HIV prevention. Biomedical
approaches to prevention, such as pre-exposure prophylaxis and treatment as prevention, require accurate and regular
HIV test results. HIV testing also represents a powerful ‘teachable moment’ for behavioural prevention. An increasing
range of HIV tests and the emergence of self-managed diagnostic technologies (e.g. self-testing) means there is now
considerable diversification of when, where and how results are available to those who test. These changes have profound
implications for intervention development and, indeed, health service redesign. This paper highlights the need for better
ways of conceptualising testing in order to capitalise on the health benefits that diverse HIV testing interventions will bring.
A multidimensional framework is proposed to capture ongoing developments in HIV testing among men who have sex
with men and focus on the intersection of: (1) the growing variety of HIV testing technologies and the associated
diversification of their pathways into care; (2) psychosocial insights into the behavioural domain of HIV testing; and
(3) better appreciation of population factors associated with heterogeneity and concomitant inequities. By considering
these three aspects of HIV testing in parallel, it is possible to identify gaps, limitations and opportunities in future HIV
testing-related interventions. Moreover, it is possible to explore and map how diverse interventions may work together
having additive effects. Only a holistic and dynamic framework that captures the increasing complexity of HIV testing is
fit for purpose to deliver the maximum public health benefit of HIV testing.
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Introduction
We propose that HIV testing has become the central health
technology for HIV prevention for both those testing positive
and negative. Pre-exposure prophylaxis (PrEP) and wider
treatment as prevention (TasP) highlight the growing challenges
of understanding the relationship between condom-less sex and
HIV transmission risk. The value of condom use as the primary
focus of prevention and behavioural surveillance is rapidly
diminishing, particularly in countries where PrEP is available.
We suggest that HIV testing now supersedes condom use as the
behavioural focus of future HIV prevention interventions
among men who have sex with men (MSM) in the developed
world. Testing presents a relatively future-proof ‘common
denominator’ in an ever-diversifying portfolio of prevention
approaches implemented in different ways across national
settings. HIV prevention approaches that rely on HIV testing
range from PrEP (which requires accurate and regular HIV
testing), across the cluster of behavioural interventions based
around serostatus (including serosorting and partner notification
interventions), to more psychological interventions in which
testing may represent a ‘teachable moment’ (by using HIV status
to galvanise the adoption and commitment to behaviour
change).1 Wherever treatments are widely available, HIV
incidence is likely to be driven by the undiagnosed fraction
of people living with HIV, and most HIV morbidity and mortality
is increasingly associated with late diagnosis.2,3 There is a
growing need to recognise the central part HIV testing plays in
diverse prevention interventions.
Because HIV testing sits at the nexus of a range of approaches
to prevention and care, it has been the focus of both increased
international scrutiny4–6 and product development within
the commercial sector. At its core, all HIV testing remains
fundamentally concerned with diagnosis (for an overview of
the function of HIV testing, see Table 1). However, recent
innovations have focused on developing diversity in the
processes that accompany this central diagnostic function.
Variations, for example, in the ability to detect recently acquired
infections, who administers the test, how long to wait for the test
results, the ways in which test results are delivered and the
combination of other tests that may accompany the HIV test (e.g.
tests for other sexually transmissible infections (STI) and blood-
borne viruses (BBV)). Perhaps associated with the focus on HIV
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testing as a preventative technology, and in relation to the
economic context of HIV service delivery in much of the
developed world, there has also been a marked turn towards
the self-management of HIV testing in recent years (e.g. self-
testing and self-sampling).
These approaches differ in that in self-testing the testee
receives and interprets the results themselves in minutes of
testing themselves. In contrast, in self-sampling, the testee
collects their sample but then sends the kit away to another
setting, where a professional interprets the results and contacts
the testee with their test results some time later. This move to
self-managed testing has happened at the same time as notable
historical and cultural shifts in both the economic context of
much of the developed world and in the mediation of the sexual
culture of MSMs away from solely physical worlds to embrace
intersections with the digital world (e.g. the availability of the
test through Internet sites or mobile phone apps).7 In this way,
testing interventions in general, and self-managed testing
interventions in particular, are increasingly being delivered
online and outwith traditional ‘bricks and mortar’ services. In
many national contexts, from the perspectives of those who are
testing, direct contact with health professionals administering
the test or sharing test results is reducing.
Over the short history of the HIV epidemic, many different
disciplines have focused on HIV testing, highlighting considerable
behavioural, social and historical variation. Since effective
antiretroviral therapies have become available, there has been
a shift in thinking of the HIV test as a relatively infrequent, one-
off event, perhaps confirming suspected HIV status, to ideas
associated with the HIV treatment cascade and getting people
living with HIV on treatment as quickly as possible to minimise
harm to their immune system and reduce population viral load.8
Equally, since the ‘normalisation’ of HIV testing9 there has
been a change in considering those who test frequently from
being pathological ‘repeat testers’ (with pejorative associations
and assumptions relating to ongoing problematic behaviour)
to focusing more on the salutogenic aspects of those people
who test regularly. People who test regularly minimise HIV
transmission risk and their accurate test results scaffold
biomedical approaches such as PrEP.
In light of these technological, social and historical changes
and the profusion of technologies, choices, processes and
behaviours associated with HIV testing, we believe it is no
longer useful to talk about HIV testing interventions or HIV
testing policy in any unitary or simplistic fashion. There will be
no single testing intervention that represents a panacea to the
ongoing problems of HIV prevention in any single population,
such as MSM. It is highly likely that multiple testing
interventions, delivered simultaneously to different sub-
populations at different times, may offer the most sustainable
and effective ways of preventing HIV transmission. There is a
growing need for clarity and shared language in thinking about
HIV testing and to acknowledge the increasing heterogeneity of
testing. We believe that in order to deliver the best of what HIV
testing can offer to HIV prevention, we need to understand HIV
testing in multidimensional ways that capture key differences in
technology, behavioural domain and population. In this way it is
possible to consider the tailoring and targeting of diverse HIV
testing interventions enabling much better purchase on issues
such as effectiveness and cost-effectiveness. In this way, further
clarity regarding the heterogeneity of HIV testing interventions
will enable us to develop cumulative knowledge and make more
use of existing evidence.
Growing variety of HIV tests and the diversification
of pathways into care
The first commercially available HIV test, an ELISA test,
entered the market in 1985. It was a blood-based test that
often took 2 weeks before results were available. Because no
effective treatment existed, all testing was accompanied by
extensive pre- and post-test counselling and was conducted
Table 1. Aims and effects of increasing uptake of HIV testing
ARVs, antiretroviral drugs; PrEP, pre-exposure prophylaxis; STI, sexually transmissible infection; PEP, post-exposure prophylaxis; BBVs, bloodborne viruses
Diagnostic
function
Individual health benefits Public health benefits
Mechanism Gain Mechanism Gain
User tests
HIV positive
1. Early access to treatment
and care
Better health outcomes Cost-effectiveness Reduced health expenditure
2. ARVs reduce viral load Better health outcomes Reduced risk of onward
transmission
Fewer new infections
3. Awareness of
HIV-positive status
Ability to adopt safer
sex practices,
such as serosorting
Opportunity to protect future
partners (e.g. PrEP,
condoms, PEP)
Fewer new infections
4. Opportunity for
partner notification
Reduced STI infections Opportunity to protect exposed
HIV-negative partners
(e.g. PEP and future
PrEP, condoms)
Fewer new infections
5. Access to behavioural
prevention
Co-infection with STIs
and/or BBVs
Identification of partners at
risk for prevention interventions
Fewer new infections
User tests
HIV negative
Opportunity for interventions
to reduce future risk
(e.g. behavioural, PrEP,
condoms)
User remains HIV
negative
Reduced risk of acquisition Identification of partners at
risk for prevention interventions
Reduced STI infections Fewer new HIV infections
Fewer new STI/BBV infections
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primarily in the domain of HIV ‘specialist centres’ or blood
banks. Although identifying primary HIV infection was not a
prime focus then, the window period, the term given to the
maximum time between HIV virus acquisition and the ability
of the test to detect the infection, would have been 3 months.
Since then, the implications of a positive diagnosis have
changed dramatically, and that, coupled with the expansion
of testing modalities, has enabled HIV testing to move beyond
the remit of specialists into the broader health community and,
finally, directly into the control of the end user.
Table 2 provides an overview of the increasingly diverse
range of tests currently available and many of their key features.
There are now a range of ways that specimens can be collected
(e.g. self-testing, point of care, self-sampling and phlebotomy).
Different HIV tests have different types of diagnostic properties
and can be delivered within an increasing range of settings.
The scale-up of testing beyond traditional healthcare settings
has been evolving from solely being offered within traditional
testing services to a wider range of settings (e.g. within
community settings or sex-on-premises testing sites). This
trend of increasing testing sites has been further expanded
following recognition of the key role undiagnosed infection
has in potentiating HIV transmission10 and because biomedical
prevention interventions have been shown to be so effective.8
International findings suggest linkage to care may be influenced
by site of diagnosis, with people testing positive in the
community setting, as opposed to clinic and other formal
healthcare settings, being less likely to be linked into and
retained in care.11 In the UK, preliminary data from the
national self-sampling pilot suggest that only 77.4% of
people with reactive tests are linked to care for confirmatory
testing.12 The relative benefit of these innovations (in that they
may reach new populations) is offset by higher attrition in the
cascade of care. Equally, the psychological impact of living
with an incorrectly assumed HIV-positive status is unknown
and, for positive people who do not start treatment, there are
Table 2. Overview of the diversity of HV tests and their characteristics
SMS, short message service; n/a, not applicable; NHS, National Health Service
Self-testing Point of care Self-sampling Phlebotomy
Time from test to
patient receiving
results
15min 1–15min 2 days–1 week (postal
dependent)
Hours to several days
Characteristics of test
result delivery
Instant (read by user) Instant (delivered by
healthcare worker)
Negative results via SMS or
secure login
Depends on setting
Reactive tests via telephone call Negative: via SMS, telephone
or face to face
Reactive: via telephone call or
face to face
Sample (blood saliva) Blood or saliva Blood or saliva Blood (TDL TINIES vial or
blood spot) or salivaA
Blood
Window periodB 3 months because all tests are
currently third generation
only
4–12 weeks 4 weeks unless saliva (then
12 weeks)
2 days–4 weeks
Antibody 12 weeks 12 weeks 12 weeks (when saliva used) n/a
Antibody and
antigen
n/a 4 weeks 4 weeks 4 weeks
RNA n/a n/a n/a 2 days
Resources required for
services
Not legally available in some
national contexts (e.g. in UK,
not available on NHS)
Staff training Cost of kit Staff training
Cost of confirmatory testing and
linkage to specialist care
Testing (average ~5min) Distribution Drawing of sample
Result notification Laboratory processing Laboratory processing
Confirmatory testing Result notification Result notification
Linkage for confirmatory testing
Physical setting of use User choice Typically sexual health
clinics, community
outreach, some primary
care services
User choice Any healthcare setting,
typically primary care
and hospital
Overt linkage
pathways into care
and surveillance
No, but information to
facilitate process can be
incorporated into kits
Yes All those with reactive results
would be contacted and
offered facilitated linkage for
confirmatory testing
Yes
Difficult to monitor testing
frequency, or linkage
into care
AIn the UK, only blood-based assays have a Conformité Européene mark; this does not include the use of dried blood spots.
BThe window period will vary according to whether the test detects antibodies, antigens or nucleic acids and can range from as little as 48 h (RNA-based
tests) to 3 months (tests detecting HIV antibodies only).
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ongoing risks to their own health and increased risks of onwards
transmission.
Testing options accessible via the Internet may be cheaper to
provide and, from the testee’s perspective, may avoid the need to
access sexual health services, which can be inconvenient and
stigma laden. Equally, the use of any face-to-face testing service
may raise fears around confidentiality for some MSM who
may not have disclosed their sexual conduct with other men
to a healthcare professional. Similarly, digital options to access
testing will be avoided by those who value the more holistic
care received via face-to-face interventions (see below). Service
providers also value choice, and the range of testing modalities
enables provision of tests best suited to their practice and the
presentation of individual cases. Point-of-care tests are used
routinely in sexual health services, but primary care clinicians
may feel they lack the infrastructure or service flexibility to
manage the unexpected reactive results and instead prefer
methods where they have more control of when and how to
deliver results. Currently in the UK, the only self-managed
testing options on the market are third-generation tests that
are less suitable for detecting recently acquired infections
than fourth-generation tests, which are not available through
self-managed routes. For MSM, this current state of affairs limits
the usefulness of self-testing in diagnosing very recent infection.
Psychosocial insights into the behavioural domain
of HIV testing
There have been problems with attempts to synthesise evidence
regarding the role of HIV testing in relation to risk behaviour,
with inconsistent accounts of the relationship between testing
and sexual behaviour change.10,13 Arguably, these problems
relate primarily to a lack of attention to the historical, social
and psychological heterogeneity of HIV testing behaviours and
a rather unitary focus on the test’s diagnostic function. At the
population level, in many counties HIV testing has changed
over time, with increases reported particularly among high-risk
populations, such as MSM.14,15 These trends reflect changes in
the meaning of HIV testing, for example in light of antiretroviral
therapy (ART) and PrEP. Currently, for example, people may
seek HIV testing in order to access treatment for HIV infection
or, conversely, to access PrEP to avoid HIV infection. Equally,
more psychologically, for the individual, across their life span
and in relation to their sexual careers, HIV testing can mean very
different things. Deeper understandings of the behavioural
domains of HIV testing (e.g. the range of testing behaviours
and their associated antecedents) and specificity in relation to
measuring HIV testing (e.g. how often and for what reason) may
enable more useful attempts to build cumulative knowledge in
relation to HIV testing in order to develop new conceptual and
analytical approaches to data analysis, evidence synthesis and
future intervention development. In the sections below and
within Table 3 we explore, from a psychological perspective,
the importance of the psychosocial, technical and temporal
context of HIV testing.
Psychosocial context of HIV testing behaviours
Understanding and responding to the psychosocial aspects of
HIV testing are vital to develop a range of behavioural
interventions in the future. In the UK, for example, on a
population level HIV risk perception is low. Most people
who perceive themselves as at risk of HIV have not recently
tested, including MSM.16 Population-level social epidemiology
regarding HIV testing, with its focus on population means, fails
to appraise the heterogeneity of testing from the perspectives of
those seeking, or indeed being offered, a test. For the individual
person seeking an HIV test there are differences in the meaning
of ‘HIV testing’ depending on their perception of the likelihood,
and the implications of, a positive diagnosis for them at that
time in their life. Fear of a positive test result remains a major
barrier to seeking HIV testing and this is patterned by perceived
likelihood of positive results.17 Testing following a perceived
risk event, for example, is considerably different from testing
that is regular or habitual. It may present very different
psychological processes than those that preceded an individual’s
previous HIV tests. Testing that was initiated by a health
professional, for example, may have required little conscious
thought or decision making for the person getting tested.
Increasing testing such as this can be achieved through
interventions that focus upon increasing opportunities for
these kinds of interactions. In contrast, following perceived
risk events, interventions may be more effective if they focus
on the deliberate, proactive, reflective decision making to seek,
or to avoid, an HIV test (akin to ‘opt-in’ testing).
In this way, even a superficial exploration of the psychosocial
context of HIV testing behaviours highlights the need for diverse
approaches to testing interventions with regard to their target
population (e.g. patient vs healthcare or community worker),
their mechanism of action (e.g. capability approaches vs
motivational approaches), anticipated positivity (e.g. high vs
low), cost-effectiveness (e.g. tolerance for high vs low resource
per test), the selection of testing technology according to the
immediacy of receiving test results (e.g. rapid vs slower pace)
and the location in which a person prefers testing to take place
(e.g. if it is a routine, expected-to-be-negative test, home testing
may be appropriate, but if positive results are expected a person
may well want to test where face-to-face support and access to
holistic care is readily available).
Technological contexts of testing behaviour
As described in the previous section, technological variation
in HIV testing is growing. This brings with it increases in the
choice of testing, as well as an increase in the scope and
complexity of what the respective tests demand from both the
testee and the test provider. Increasing choice of test is
important because it relates to potential reductions in barriers
to testing by increasing opportunities to test and enables the
tailoring of different tests to specific psychosocial, cultural or
service provision contexts. We believe facilitating choice in
tailoring testing technology represents a novel and viable locus
of intervention development for MSM.
Interventions that focus on choice and increasing
opportunities to test must also address issues of capability
because different tests demand different levels of skills, health
literacy and, in some national contexts, material resources. With
regard to self-managed tests, dry blood spot approaches demand
a distinct behavioural repertoire (i.e. drawing and managing
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Table 3. Psychological patterning of HIV testing and potential implications for services and intervention development
MSM, men who have sex with men; PrEP, pre-exposure prophylaxis; STI, sexually transmissible infection
Psychological issues for testee Service implication Intervention opportunities
Testing in response to a ‘one-off’
perceived risk event
Assumes recognition of risk Medium positivity potential Suggests ongoing population-level
interventions to educate MSM to recognise
risk (e.g. after PrEP)
Perceived risk of infection is high Waiting period (due to window
period and processing delays)
and rapid results
The testing experience may represent a
teachable moment: boost behavioural
interventions to maintain safer behaviour or
initiate PrEP if available
Reflective decision-making
process should be targeted
within intervention mechanism
of action
Arrange provision of support Provides an entry into pathway for care and
secondary prevention for positive tests
Potential high levels of distress Arrange provision of range of STI
tests
Consideration of approaches such as below
Arrange intensive partner
notification
Tolerance for higher-cost HIV
tests
Testing in relation to ongoing
high-risk behaviour
Perceived risk may be high Challenge of identifying group of
ongoing high-risk MSM or
intravenous drug users
Personalised risk assessment may be useful
for fostering testee and professional
recognition of patterns of risk behaviour
Other priorities may be more
important than HIV risk
Ensure positive experience to
encourage habit formation of
service use
Intensive intervention may be needed to
change the maintenance of problematic
behaviour change
Distal determinants of ongoing
risk behaviour may be
important (i.e. syndemics)
Establish relationship and
continuation of care
Reminders, triggers, behavioural prompts
Arrange intensive partner
notification
Testing bundles (wide range of STI and
blood-borne viruses) may be appropriate
Focus on patient choice given
their potential diverse service
needs
Referral for PrEP
Explore provision of testing
bundles of STIs (convenience
and self-management)
Candidates for intensive behavioural
prevention that addresses the wider
psychological and social determinants of
riskHigh positivity risk (HIV), high
STI risk
Testing in relation to higher risk
due to group membership, or
area of high HIV prevalence
rather than risk behaviour per se
High HIV awareness but possibly
low risk perception
Challenge of identifying group
and encouraging testing
without stigmatizing
Suggests identity-related interventions should
be considered
Maintenance of group
membership
Ensure positive experience Suggests interventions that focus on
normative influence, social capital and
social context should be considered
Establish relationship and
continuation of care
Norm-based interventions that focus on
prompts for repeat testing and peer support
for testing should be considered
Focus on patient choice Focus on salutogenic issues and resilience
Provision of testing bundles of
STIs (convenience and self-
management)
Intensive partner notification
First ever test Reflective decision making Ensure positive experience and
establish a sense of habit
School-based interventions should be
considered to increase opportunities to test
Associated with younger age or
recent MSM conduct
Normalise experience Mass media interventions should be
considered to increase motivation and
capability to test
Routine partner notification Age-related interventions may capitalise on
community norms
Identity-related interventions may work,
particularly for younger men and men
recently coming out
(continued next page)
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blood samples) compared with those associated with tests that
use saliva. Equally, online ordering of test kits to be delivered
to the home requires a set of different skills, behaviours and
resources than those needed to travel to a testing site, book
appointments and interact with a health professional. The
interplay of psychosocial issues with the demand dimensions
of the range of testing technologies remains underexplored, yet
vital to harnessing future HIV testing interventions. It also
highlights the importance of attending to health, social and
economic inequalities and the structural determinants of testing.
The heterogeneity of health care contexts and the varying
accessibility of the range of testing approaches across national
settings provide an interesting natural experimental design for
monitoring choice-based testing interventions.
Temporal contexts
The historical nature of evidence concerning HIV testing
interventions may limit its transferability to current contexts.
However, we would argue it is also important to focus on the
temporal aspects of an individual and what could be termed
their testing career. The usefulness of population-level testing
surveillance will be increasingly compromised if the temporal
dimensions of individual testing patterns are not adequately
addressed. The effectiveness of ART in reducing transmission
among those living with HIV and those who take PrEP has
stressed the importance of considering the temporal dimensions
of HIV testing in the life context. Only test results that accurately
reflect recent infection, or lack of infection, are useful to enable
these biomedical preventative approaches. Older ways of
thinking about testing that centred on diagnosis and access
to treatment alone increasingly limit our thinking of testing
interventions. This vestigial thinking that focuses on the
dichotomy and durability of positive and negative test results
limits our insights into the undiagnosed fraction of positive
people, especially in those who have had a previous negative
HIV test result.18 Measurement tools, data analysis and lay
understandings often continue to focus on the dichotomy of
‘ever versus never’ tested rather than focusing on testing rates
among those at ongoing risk. Equally, studies that conflate
recency of testing with regularity of testing obscure the focus
on regular, time-bound, repeat testing as a key behavioural
goal necessary for fully using HIV testing for 2020. A deeper
understanding of the frequency of testing, or inter-test intervals,
is required19 to consolidate testing interventions for the future.
Behavioural interventions must focus on specific aspects of
the HIV testing domain (e.g. in the UK, targeting frequent
self-sampling approaches among MSM at high risk, such as
every 12 weeks, rather than annual testing through self-testing
among the whole MSM population).
Population factors: heterogeneity of the MSM population
and associated inequities
Social epidemiology tends to aggregate groups of people at
the population level; for example, in the UK, ‘MSM’ versus
‘Black African’ as two primary populations at most risk of HIV.
However, an appreciation of the heterogeneity of the MSM
population (e.g. Table 4) in relation to HIV testing, across
a range of dimensions, may lead to effective targeting of
limited resources. As evidence of effectiveness of testing
interventions develops, subpopulation specificity, or concerns
about transferability in the MSM population, should be
systematically highlighted. This ‘granular’ understanding of
the MSM population would enable consideration of a range
of simultaneous testing interventions, each addressing specific
subpopulations; this enables consideration of developing
testing interventions in relation to inequalities and the social
determinants of testing. Such a pluralistic approach to
understanding MSM and diverse testing interventions may
ensure that testing interventions do not amplify health
inequities in the MSM population as a whole. Instead, a
range of acceptable and effective testing interventions could
be available that can be tailored via user preference, capability
and subpopulation specificity. Considerations of population
segmentation highlight the stratification of effectiveness and
cost-effectiveness. In as much as what works for one group
of men (e.g. those that use the Internet and telephone apps
regularly) may not work for others (MSM in rural communities
with no 4G coverage) or, indeed, for the MSM population as
a whole (e.g. social marketing or mass media approaches20).
Furthermore, subpopulation segmentation illuminates cost-
effectiveness in relation to those who can only be reached
by particularly expensive interventions.
Focus on barriers to testing
Barriers to testing represent a key way of considering
population specificity. Among those who can acknowledge
their vulnerability to HIV infection, grouping individuals
according to their perceived barriers to testing can enable a
useful and tailored repertoire of testing interventions. Targeting
motivation-based testing interventions that focus on persuading
those who are fearful of testing needs to be distinct from
opportunity-based interventions, which target people who, for
example, wish to seek testing but struggle to use current testing
provision. Equally, where testing is readily available, not testing
may relate to a failure to recognise risk exposure,16 thus
highlighting the need for educational approaches delivered
to the whole population. These different intervention targets
demand interventions with different mechanisms of action and
different modes of delivery.
Table 3. (continued )
Psychological issues for testee Service implication Intervention opportunities
Routine testing as sexual health
screen
Low risk perception Minimal attention to HIV per se Interventions could focus on effective
prompts for timely return to services
Low positivity risk Focus on salutogenic issues and resilience
Routine partner notification Explore self-managed testing interventions (e.
g. postal delivery)
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Lifespan perspectives
Key differences exist in relation to testing with regard to a
person’s life context. These are reflected the international
literature, demonstrating strong positive correlations between
age and testing.21 Regardless of perceived risk, testing for the
first time may be associated with increased anxiety compared
with repeat, habitual or routine testing later within sexual careers
(e.g. as a necessary precursor to accessing PrEP). These lifespan
perspectives may offer purchase to designing particular
interventions for particular groups; for example, considering
targeted interventions for young MSM that foster routine testing
behaviours (including HIV) coupled with human papillomavirus
vaccination or a focus on MSM in relationships.22
Health and digital literacy
Many of the preceding sections have touched on issues relating
to health literacy (e.g. the ability to recognise prior or potential
risk through an understanding of the sometimes-complex factors
associated with HIV transmission). Addressing issues of
health literacy is likely to be of fundamental importance to
consolidating the opportunities available for HIV testing
interventions.23 Equally, the various testing technologies
available present a range of user demands differentially
requiring degrees of literacy, numeracy and manual dexterity.
Moreover, because some of the self-managed tests lend
themselves to digital distribution, it is important to acknowledge
that although this approach removes barriers for some (e.g.
those seeking to test in rural areas with little alternative
testing provision), it may create barriers for others.24 Such
approaches necessitate a viable Internet connection and assume
material and technical resources in order to be effective. In this
way, even at a rural population level, although online self-
testing interventions may prove a pragmatic and effective
way of increasing testing, they are likely to so do only in a
specific subpopulation (those with digital literacy and a
particular level of material and technological resources). They
may poorly serve those who may need HIV testing most.
Table 4. Population factors and their relationship to HIV testing
MSM, men who have sex with men; BME, black and minority ethnic
Population dimension Implications for interventions
Barriers to testing Segment the population according to their barriers to testing to target different interventions
Interventions may focus only on those who already have decided to test (e.g. focusing on choice and using user preference
for technologies to facilitate regular testing)
Interventions may focus on persuading those who may need to test to actually test through addressing the antecedents
of testing decisions (e.g. focus on costs and benefits of testing)
Interventions may focus on engaging those who are disengaged with HIV and are unaware of their risk (e.g. use mass media
and focus on maximum reach)
Self-complete personalised risk assessment may be a viable tool to enable people to realise the need to test or when
to test (see Table 2), but this assumes a level of health literacy and prior engagement with the issue of HIV risk
Intervene not only in relation to reducing barriers and increasing enablers to testing per se, but also to the particular use
of the particular test (e.g. focus on reducing barriers to the use of self-managed blood spot-based testing)
Address service provider barriers to testing, such as targeting key, difficult-to-reach but epidemiologically relevant
subpopulations to increase opportunities for routine, wider sexual health screening and wider service uptake
Lifespan perspectives Target and tailor interventions to establish testing within the young and testing patterns across the lifespan, thus promoting
habit overall but also using different intervention approaches for different groups (e.g. differential use of social influence,
such as descriptive, injunctive or personal norms according to life stage)
Encourage and establish routine habitual HIV testing practices within health and community test providers new
to post to foster habit formation use across their career
Geographic
considerations
Distance from traditional health and community services may be prohibitive to testing (rural populations may benefit from
different testing interventions to more urban populations)
Accessing local services for small, closely knit communities may be problematic for perceptions of confidentiality
(e.g. provide range of self-managed tests, such as self-sampling)
Digital services may be mediated by geography, both compromised (lack of digital infrastructure) or enhanced
(primary means of communication in dispersed populations)
Postal self-sampling and testing options need to be able to be delivered conveniently and safely (e.g. packages should fit
through standard mail slot)
A variety of kit-collection options should exist (e.g. harnessing user preference and perceptions of control)
Health literacy
considerations
Consider how choice of test or interventions to encourage testing behaviour may relate to the test kit’s specific user
demands: what are the user requirements in relation to issues such as understanding of the window period, meaning
of reactive results
Consider health literacy issues among the diverse provider populations who may offer the HIV test
Digital literacy
considerations
Consider how accessing the test may presume digital literacy and economic resource with regard to the use of online
service delivery
Intersectionality,
syndemics and
social vulnerability
Consider particular vulnerabilities of MSM who are BME, trans, use substances, have learning difficulties
or who have mental health or poorer physical health
Interventions designed to cover more syndemic or ‘upstream’ determinants of ill health may be needed to complement
the proximal behavioural and psychological focus of HIV testing
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Intersectionality, syndemics and social vulnerability
Finally, it is important to consider the specificity of
subpopulations by traditional sociodemographic features and
their intersections. The particular vulnerabilities of Black and
minority ethnic MSM are well documented in some national
contexts.25–28 Yet, how these vulnerabilities intersect with other
important markers, such as age and poverty, are not well
documented. Equally, the relationships between vulnerabilities
and testing technology and the behavioural domain of HIV
testing remain underexplored to date.
Discussion
If we are to maximise the individual and public health benefits
presented by HIV testing interventions, we must think beyond
the HIV test’s diagnostic function and consider the technological,
psychosocial and sociocultural contexts of HIV testing. The
increasing diversification of the tests available demands
systematic consideration of the right test for particular
circumstances and particular subpopulations and recognises
that, over time, the same person may well require different
testingmethods and settings. This multidimensional understanding
of HIV testing will be important for patient preference, yet,
scaled-up, it is equally important for considering the distribution
of resources to support intervention design and, indeed, to make
the most of available evidence detailing the effectiveness of
testing intervention.
There is a danger that by not grasping the complexity of HIV
testing and harnessing its emerging pluralities we will only reach
the low-hanging fruit: designing, evaluating and implementing
testing interventions that work for limited groups of people but
do not affect the actual drivers of HIV transmission. There is a
concern that if we only invest in one or two testing interventions
and remove others, we may not affect HIV incidence and,
indeed, we may be doing harm. For example, investing solely
in interventions that work for urban gaymenwho use the Internet
may systematically fail to provide testing interventions for men
with low levels of health and digital literacy, amplifying health
inequities. Embracing the complexity and plurality of testing
interventions leads to the development of a programmatic and
systemic approach to HIV testing interventions. Subsequent
research questions focus on how best to use available evidence
from specific interventions with clear population parameters and
how best to offer combinations of a range of interventions
concurrently. These create ways of imagining new research
questions (by testing technology, by the kind of testing
decisions being targeted by interventions and by subpopulation
parameters). They facilitate comparative research questions
addressing the relative effectiveness of a variety of testing
interventions and create ways of systematically thinking
about ways of combining distinct yet complementary HIV
testing interventions to address health inequalities and
multiple barriers to testing.
In Table 5 we summarise the key dimensions of HIV testing
we have identified within the paper; these are not exhaustive.
We hope that these will prove useful in retrospectively
considering the ways we describe HIV testing interventions
and their effectiveness in order to build useful knowledge for
future service provision through evidence synthesis. Moreover,
we think these dimensions may also be useful for considering
new ways of conceptualising future interventions and
understanding the opportunities and limitations of current
interventions. We believe that better interventions can be
developed and described if we engage with this level of
specificity (e.g. rather than describing ‘Internet-delivered
testing interventions’ we can suggest ‘using self-tests to
target those mid-sexual career men who are seeking to test
because of ongoing risk behaviour and who live in areas well
served by Internet connections’). This is useful because it
helps consolidate a nuanced evidence base. It also indicates
who is likely to be excluded from engaging with the specified
intervention and encourages us to think about who may require
alternative interventions. For example, in relation to the
example given, a complementary intervention may be needed
that uses point-of-care testing in primary care and targets those
who are in need of persuasive interventions to test in response
to a ‘one-off’ perceived high-risk event or those who lack the
material or psychological resources to use an HIV self-test kit.
The dimensions, as listed, also facilitate an understanding of
the differences in the economic, legislative and cultural context
of nations, states or provinces that also constrain the possible
parameters of these dimensions.
Table 5. Important dimensions to consider when describing and developing HIV testing interventions
Define the testing technologies
used within an intervention
The specific context of HIV testing
targeted in interventions
Dimensions to consider in relation to targeting
populations for interventions
Self-testing Testing in response to a ‘one off’ perceived
high risk event
Barrier to testing (e.g., already made the decision
to test vs need persuading to test)
Self-sampling Testing in relation to on-going high risk behavior Lifespan perspective (e.g., newly ‘out’, sexual debut)
Point of care Testing in relation to higher risk due to group
membership, or area of high HIV prevalence rather
than risk behaviour per se
Geographical considerations (e.g., urban, rural, 3G, 4G)
Phlebotomy First ever test Health literacy considerations
Characteristics of
result delivery
Routine testing as sexual health screen Digital literacy considerations
Setting of test process Testing in response to a ‘one off’ perceived risk event Intersectionality, syndemics and social vulnerability
Window period Testing in relation to on-going high risk behavior
The type of sample used
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